Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Current Leases (2020 - 2026)

Maxcyte has reported Current Leases over the past 6 years, most recently at $1.5 million for Q4 2025.

  • Quarterly Current Leases rose 68.52% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 68.52% year-over-year, with the annual reading at $1.5 million for FY2025, 68.52% up from the prior year.
  • Current Leases was $1.5 million for Q4 2025 at Maxcyte, up from $1.3 million in the prior quarter.
  • Over five years, Current Leases peaked at $1.5 million in Q4 2025 and troughed at $152200.0 in Q3 2022.
  • The 5-year median for Current Leases is $698700.0 (2023), against an average of $748347.4.
  • Year-over-year, Current Leases plummeted 73.41% in 2022 and then soared 392.99% in 2023.
  • A 5-year view of Current Leases shows it stood at $527200.0 in 2021, then tumbled by 70.22% to $157000.0 in 2022, then skyrocketed by 392.99% to $774000.0 in 2023, then increased by 11.63% to $864000.0 in 2024, then soared by 68.52% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Current Leases are $1.5 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).